{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T22:51:14Z","timestamp":1689893474977},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00105-020-04697-x","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T08:05:14Z","timestamp":1601453114000},"page":"880-886","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pyoderma gangraenosum: durch zielgerichtete Therapieans\u00e4tze besser verstehen und behandeln k\u00f6nnen"],"prefix":"10.1007","volume":"71","author":[{"given":"R.","family":"Rongisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Koll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Eming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"4697_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ceb.2016.04.001","volume":"42","author":"TJ Shaw","year":"2016","unstructured":"Shaw\u00a0TJ, Martin\u00a0P (2016) Wound repair: a\u00a0showcase for cell plasticity and migration. Curr Opin Cell Biol 42:29\u201337","journal-title":"Curr Opin Cell Biol"},{"key":"4697_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaz9631","author":"IC Boothby","year":"2020","unstructured":"Boothby\u00a0IC, Cohen\u00a0JD, Rosenblum\u00a0MD (2020) Regulatory T cells in skin injury: at the crossroads of tolerance and tissue repair. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aaz9631","journal-title":"Sci Immunol"},{"key":"4697_CR3","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1021\/pr100456d","volume":"9","author":"SA Eming","year":"2010","unstructured":"Eming\u00a0SA, Koch\u00a0M, Krieger\u00a0A et\u00a0al (2010) Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J\u00a0Proteome Res 9:4758\u20134766","journal-title":"J Proteome Res"},{"key":"4697_CR4","doi-asserted-by":"publisher","first-page":"265sr6","DOI":"10.1126\/scitranslmed.3009337","volume":"6","author":"SA Eming","year":"2014","unstructured":"Eming\u00a0SA, Martin\u00a0P, Tomic-Canic\u00a0M (2014) Wound repair and regeneration: machanisms, signaling, and tranlation. Sci Transl Med 6:265sr6","journal-title":"Sci Transl Med"},{"key":"4697_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19027","author":"JD Lu","year":"2020","unstructured":"Lu\u00a0JD, Hobbs\u00a0MM, Huang\u00a0WW et\u00a0al (2020) Identification and evaluation of outcome measurement instruments in pyoderma gangraenosum: a\u00a0systematic review. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.19027","journal-title":"Br J Dermatol"},{"key":"4697_CR6","first-page":"32","volume":"17","author":"K Herberger","year":"2019","unstructured":"Herberger\u00a0K, Dissemond\u00a0J, Br\u00fcggestrat\u00a0S et\u00a0al (2019) Biologika und Immunglobuline f\u00fcr die Therapie des Pyoderma gangraenosum \u2013 Analyse von 52\u00a0Patienten. J\u00a0Dtsch Dermatol Ges 17:32\u201342","journal-title":"J Dtsch Dermatol Ges"},{"key":"4697_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13389","author":"MM Hobbs","year":"2020","unstructured":"Hobbs\u00a0MM, Ortega-Loyaza\u00a0AG (2020) Pyoderma gangraenosum: from historical perspectives to emerging investigations. Int Wound\u00a0J. https:\/\/doi.org\/10.1111\/iwj.13389","journal-title":"Int Wound J"},{"key":"4697_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/1744666X.2018.1438269","volume":"14","author":"C Ahn","year":"2018","unstructured":"Ahn\u00a0C, Negus\u00a0D, Huang\u00a0W (2018) Pyoderma gangraenosum: a\u00a0review of pathogenesis and treatment. Expert Rev Clin Immunol 14:225\u2013233","journal-title":"Expert Rev Clin Immunol"},{"key":"4697_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","volume":"18","author":"A Alavi","year":"2017","unstructured":"Alavi\u00a0A, French\u00a0LE, Davis\u00a0MD et\u00a0al (2017) Pyoderma gangraenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol 18:355\u2013372","journal-title":"Am J Clin Dermatol"},{"key":"4697_CR10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/bjd.13493","volume":"172","author":"EM DeFilippis","year":"2015","unstructured":"DeFilippis\u00a0EM, Feldman\u00a0SR, Huang\u00a0WW (2015) The genetics of pyoderma gangraenosum and implications for treatment: a\u00a0systematic review. Br J Dermatol 172:1487\u20131497","journal-title":"Br J Dermatol"},{"key":"4697_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10875-015-0155-3","volume":"35","author":"M Madkaikar","year":"2015","unstructured":"Madkaikar\u00a0M, Italia\u00a0K, Gupta\u00a0M et al (2015) Leukocyte adhesion deficiency\u2011I with a\u00a0novel intronic mutation presenting with pyoderma gangraenosum-like lesions. J\u00a0Clin Immunol 35:431\u2013434","journal-title":"J Clin Immunol"},{"key":"4697_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","volume":"162","author":"AV Marzano","year":"2010","unstructured":"Marzano\u00a0AV, Cugno\u00a0M, Trevisan\u00a0V et al (2010) Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162:100\u2013107","journal-title":"Clin Exp Immunol"},{"key":"4697_CR13","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/bjd.15226","volume":"176","author":"AV Marzano","year":"2017","unstructured":"Marzano\u00a0AV, Damiani\u00a0G, Ceccherini\u00a0I et\u00a0al (2017) Autoinflammation in pyoderma gangraenosum and its syndromic form (pyoderma gangraenosum, acne and suppurative hidradenitis). Br J Dermatol 176:1588\u20131598","journal-title":"Br J Dermatol"},{"key":"4697_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10620-018-4971-1","volume":"63","author":"M Fleisher","year":"2018","unstructured":"Fleisher\u00a0M, Marsal\u00a0J, Lee\u00a0SD et\u00a0al (2018) Effects of vedolizumab therapy on extraintestinal manifestations in inflammatory bowel disease. Dig Dis Sci 63:825\u2013833","journal-title":"Dig Dis Sci"},{"key":"4697_CR15","unstructured":"https:\/\/clinicaltrials.gov, Abgerufen am 9. Aug. 2020"},{"key":"4697_CR16","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.jaad.2018.08.068","volume":"80","author":"E Maverakis","year":"2019","unstructured":"Maverakis\u00a0E, Le\u00a0ST, Callen\u00a0J et\u00a0al (2019) New validated diagnostic criteria for pyoderma gangraenosum. J\u00a0Am Acad Dermatol 80:e87\u2013e88","journal-title":"J Am Acad Dermatol"},{"key":"4697_CR17","doi-asserted-by":"crossref","unstructured":"Haag\u00a0C, Hansen\u00a0T, Hajar\u00a0T et al (2020) Comparison of three diagnostic frameworks for pyoderma gangrenosum. J Invest Dermatol (online ahead of print)","DOI":"10.1016\/j.jid.2020.04.019"},{"key":"4697_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00292-020-00784-x","volume":"41","author":"SMC M\u00f6ckel","year":"2020","unstructured":"M\u00f6ckel\u00a0SMC, Metze\u00a0D (2020) Neutrophilic and pustular dermatoses: new autoinflammatory diseases and syndromes. Pathologe 41:364\u2013370","journal-title":"Pathologe"},{"key":"4697_CR19","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1056\/NEJMicm1410236","volume":"373","author":"S Emmert","year":"2015","unstructured":"Emmert\u00a0S, Sch\u00f6n\u00a0MP (2015) Images in clinical medicine. Squamous-cell carcinoma resembling pyoderma gangraneosum. N\u00a0Engl J Med 373:e5","journal-title":"N Engl J Med"},{"key":"4697_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00105-010-2115-4","volume":"62","author":"R L\u00f6hrer","year":"2011","unstructured":"L\u00f6hrer\u00a0R, Eming\u00a0R, Wolfrum\u00a0N et\u00a0al (2011) Autoinflammatory diseases as cause of wound healing defects. Hautarzt 62:524\u2013533","journal-title":"Hautarzt"},{"key":"4697_CR21","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1111\/bjd.15901","volume":"178","author":"AGA Kolios","year":"2018","unstructured":"Kolios\u00a0AGA, Hafner\u00a0J, Luder\u00a0C et\u00a0al (2018) Comparison of pyoderma gangraenosum and Martorell hypertensive ischaemic leg ulcer in a\u00a0Swiss cohort. Br J Dermatol 178:e125\u2013e126","journal-title":"Br J Dermatol"},{"key":"4697_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","volume":"23","author":"E Ruocco","year":"2009","unstructured":"Ruocco\u00a0E, Sangiuliano\u00a0S, Gravina\u00a0AG et\u00a0al (2009) Pyoderma gangraenosum: an updated review. J\u00a0Eur Acad Dermatol Venereol 23:1008\u20131017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4697_CR23","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2020.1168","author":"D Croitoru","year":"2020","unstructured":"Croitoru\u00a0D, Naderi-Azad\u00a0S, Sachdeva\u00a0M et al (2020) A wound care specialist\u2019s approach to pyoderma gangraenosum. Adv Wound Care. https:\/\/doi.org\/10.1089\/wound.2020.1168","journal-title":"Adv Wound Care"},{"key":"4697_CR24","doi-asserted-by":"publisher","first-page":"h2958","DOI":"10.1136\/bmj.h2958","volume":"350","author":"AD Ormerod","year":"2015","unstructured":"Ormerod\u00a0AD, Thomas\u00a0KS, Craig\u00a0FE et\u00a0al (2015) Comparison of the two most commonly used treatments for pyoderma gangraenosum: results of the STOP GAP randomized controlled trial. BMJ 350:h2958","journal-title":"BMJ"},{"key":"4697_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00105-020-04610-6","volume":"71","author":"E Hadaschik","year":"2020","unstructured":"Hadaschik\u00a0E, Eming\u00a0R, French\u00a0L et\u00a0al (2020) Europ\u00e4ische Leitlinien (S1) f\u00fcr die Verwendung von hoch dosierten intraven\u00f6sen Immunglobulinen in der Dermatologie. Hautarzt 71:542\u2013552","journal-title":"Hautarzt"},{"key":"4697_CR26","first-page":"1","volume":"9","author":"KK Wu","year":"2020","unstructured":"Wu\u00a0KK, Dao\u00a0H Jr (2020) Off-label dermatologic used of IL-17 inhibitors. J\u00a0Dermatolog Treat 9:1\u20137","journal-title":"J Dermatolog Treat"},{"key":"4697_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2230.2012.04375.x","volume":"38","author":"JA Palanivel","year":"2013","unstructured":"Palanivel\u00a0JA, Macbeth\u00a0AE, Levell\u00a0NJ (2013) Pyoderma gangraenosum in association with Janus kinase 2 (JAK2V617F) mutation. Clin Exp Dermatol 38:44\u201346","journal-title":"Clin Exp Dermatol"},{"key":"4697_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/gut.2005.074815","volume":"55","author":"TN Brooklyn","year":"2006","unstructured":"Brooklyn TN, Dunnill MGS, Shetty A et al (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55:505\u2013509","journal-title":"Gut"},{"key":"4697_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/wound.2020.1160","volume":"9","author":"K Eisendle","year":"2020","unstructured":"Eisendle\u00a0K, Thuile\u00a0T, Deluca\u00a0J et\u00a0al (2020) Surgical treatment of pyoderma gangraenosum with negative pressure wound therapy and skin grafting. Including xenografts: personal experience and comprehensive review on 161\u00a0cases. Adv Wound Care 9:405\u2013425","journal-title":"Adv Wound Care"},{"key":"4697_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bjps.2017.08.013","volume":"71","author":"K Schwaiger","year":"2018","unstructured":"Schwaiger\u00a0K, Russe\u00a0E, Kholosy\u00a0H et\u00a0al (2018) Reconstructive microsurgical approach for the treatment of pyoderma gangraenosum. J\u00a0Plast Reconstr Aesthet Surg 71:44\u201352","journal-title":"J Plast Reconstr Aesthet Surg"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04697-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-020-04697-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04697-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T08:48:02Z","timestamp":1669020482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-020-04697-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4697"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04697-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"30 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Rongisch, P.\u00a0Koll und S.A.\u00a0Eming geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}